Genomics plc
Genomics plc is a spin-out company from the University of Oxford founded in 2014 by Professors Peter Donnelly and Gilean McVean,[1] with the aim of creating a platform that can use genetic and phenotypic big data coupled with advanced algorithms to elucidate the human wiring diagram.[2] The company has raised around £10M in funding [1] and is using its platform to help pharmaceutical companies improve and de-risk their drug development pipelines [3][4][5] as well supporting other prominent projects such as the Genomics England 100,000 Genomes project.[6]
References
- 1 2 "'Series A funding announcement". Retrieved August 19, 2016.
- ↑ "Official Website". Retrieved August 19, 2016.
- ↑ "'Eisai Partnership announcement". Retrieved August 19, 2016.
- ↑ "'Vertex Partnership announcement". Retrieved August 19, 2016.
- ↑ "'Biogen Partnership announcement". Retrieved August 19, 2016.
- ↑ "'Festival of Genomics Exhibition Preview Genomics plc". Retrieved August 19, 2016.
External links
- Funding announcement
- Official website
- Eisai Partnership announcement
- Vertex partnership announcement
- Biogen partnership announcement
- Fontline Genomics article
This article is issued from Wikipedia - version of the 10/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.